Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Ketoconazolum

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 15 USDMF, 7 CEP/COS, 3 JDMF, 6 EU WC, 13 KDMF, 25 NDC API, 34 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

58 Drugs in Development

58 Drugs in Development

INTERMEDIATES

33 Intermediate Suppliers

33 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers, 28 FDA Orange Book, 21 Europe, 4 Canada, 10 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SHAMPOO;TOPICAL - 1%, AEROSOL, FOAM;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 5 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 10 Kirsch Pharma, 13 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 34 BASF, 2 BioSpectra, 3 CD Formulation, 1 Clariant, 1 Corel Pharma Chem, 4 DFE Pharma, 3 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Ideal Cures, 2 Ingredion Pharma Solutions, 12 Kerry, 1 Keval Exports, 2 Lubrizol Life Science Health, 11 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 13 Roquette, 17 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Topical, 49 Fillers, Diluents & Binders, 41 Solubilizers, 40 Thickeners and Stabilizers, 34 Parenteral, 23 Direct Compression, 20 Granulation, 19 Emulsifying Agents, 16 Surfactant & Foaming Agents, 14 Co-Processed Excipients, 13 Lubricants & Glidants, 12 Controlled & Modified Release, 10 Film Formers & Plasticizers, 8 Disintegrants & Superdisintegrants, 8 Chewable & Orodispersible Aids, 7 Taste Masking, 7 Rheology Modifiers, 7 Coating Systems & Additives, 4 API Stability Enhancers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 15 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 12 Regulatory FDF Prices

MARKET PLACE

45 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Aarti Drugs	India	AARTI DRUGS LIMITED Mumbai IN	CEP 2023-309 - Rev 00	Ketoconazole	2025-09-10	Valid	Chemical		921
29/11/2025	Derivados Quimicos SAU	Spain	DERIVADOS QUIMICOS S.A. Alcantarilla ES	CEP 2016-102 - Rev 04	Ketoconazole	2025-09-25	Valid	Chemical		921

Ketoconazolum

Ketoconazolum

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers

15 USDMF

7 CEP/COS

3 JDMF

6 EU WC

13 KDMF

25 NDC API

34 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

58 Drugs in Development

INTERMEDIATES

33 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

113 FDF Dossiers

28 FDA Orange Book

21 Europe

4 Canada

10 South Africa

50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SHAMPOO;TOPICAL - 1%

AEROSOL, FOAM;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

5 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

3 Gangwal Healthcare

11 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

10 Kirsch Pharma

13 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

34 BASF

2 BioSpectra

3 CD Formulation

1 Clariant

1 Corel Pharma Chem

4 DFE Pharma

3 Esteem Industries

3 Finar

12 Gangwal Chemicals

1 Ideal Cures

2 Ingredion Pharma Solutions

12 Kerry

1 Keval Exports

2 Lubrizol Life Science Health

11 Microlex e.U

2 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

5 Pluviaendo

2 Prachin Chemical

13 Roquette

17 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

8 Sigachi Industries

2 Silverline Chemicals

1 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

TABLET;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SHAMPOO;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons